AMC Entertainment is planning to reinvest up to $1.5 billion in its theaters but faces a balancing act amid debt repayments, ...

Dan Ives, Wedbush Securities analyst, joins CNBC's 'Squawk on the Street' to discuss outlooks on Tesla following Donald Trump ...

M/I Homes (MHO) was trading higher after Wedbush Securities upgraded the home builder on a better-than-expected business ...

The question is how much, and we just don't know right now," Wedbush Securities analyst Brian Violino told CBS MoneyWatch.

Wedbush has a “Outperform” rating and a $33.00 price objective on the stock. The consensus estimate for Day One Biopharmaceuticals’ current full-year earnings is ($1.65) per share.

Wedbush analyst Matt Bryson lowered the firm’s price target on Supermicro (SMCI) to $32 from $62 and keeps a Neutral rating on the ...

With a Donald Trump win for the White House looking very likely, Wedbush expects a “very robust bullish market reaction.” The ...

Wedbush analyst S. Devitt now anticipates that the company will post earnings per share of $0.26 for the year, up from their prior forecast of ($0.05). Wedbush currently has a “Neutral” rating ...

Wedbush added Roblox (RBLX) to the firm’s “Best Ideas List” while keeping an Outperform rating on the shares with a $49 price ...

Wedbush Securities upgraded shares of Affirm (AFRM) and Upstart Holdings (UPST) from Underperform to Neutral; the analyst team also upped both companies' price targets to $45 per share.

Dan Ives expects Trump's victory to be a boon for Tesla stock. The Wedbush analyst explained why in an interview with CNBC ...

Financial services firm Wedbush Securities is moving from a prominent office tower in downtown Los Angeles to Pasadena, where it will occupy much smaller offices meant to accommodate hybrid work ...